Abortion

Abortion | Chapter 4 Preface

In September 2000, the Food and Drug Administration (FDA) approved the sale of the drug mifepristone, also known as RU-486, for use in nonsurgical abortions occurring within the first seven weeks of pregnancy. The procedure entails a two-drug combination: Mifepristone causes the uterus to shed its lining and dislodge the embryo; then misoprostol, taken two days later, induces contractions that expel the remaining tissue. While abortion rights supporters hailed the FDA’s announcement as a breakthrough for American women, opponents condemned it as a move that would endanger human life...

[The entire page is 329 words long]

Join eNotes

The above is a free excerpt. Get total access to this content with the:

eNotes Pass